Celemics, Inc.
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
331920 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 가산디지털1로 131, A동 19층 및 20층 2004호 외, 금천구
- Website:
- https://www.celemics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Celemics, Inc. is a biotechnology company specializing in Next-Generation Sequencing (NGS) solutions for research and clinical diagnostics. The company develops and manufactures a comprehensive portfolio of products, including hybridization-based NGS target enrichment panels, whole exome sequencing (WES) kits, library preparation kits, and bioinformatics analysis services. Utilizing proprietary technologies in probe design, molecular barcoding, and bioinformatics, Celemics provides both ready-to-use and fully customized panels tailored for various applications. Its key markets include oncology, liquid biopsy, biopharma, inherited disease analysis, pharmacogenomics, pathogen detection, and agrigenomics, offering end-to-end solutions from assay development to data analysis.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Celemics, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all Celemics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Celemics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
